Prelude Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,900
Closed -$88K 2340
2019
Q4
$88K Buy
+13,900
New +$81.7K ﹤0.01% 1159
2019
Q2
Sell
-74,500
Closed -$395K 2388
2019
Q1
$395K Buy
+74,500
New +$340K 0.02% 546
2018
Q4
Sell
-8,000
Closed -$22K 2436
2018
Q3
$22K Buy
+8,000
New +$22.5K ﹤0.01% 1299
2018
Q1
Sell
-9,448
Closed -$28K 1918
2017
Q4
$28K Buy
+9,448
New +$26.1K ﹤0.01% 1062
2017
Q3
Sell
-100
Closed 2127
2017
Q2
$0 Sell
100
-16,900
-99% -$35.7K ﹤0.01% 2080
2017
Q1
$32K Buy
+17,000
New +$32.8K ﹤0.01% 1173
2016
Q1
Sell
-8,201
Closed -$39K 1797
2015
Q4
$39K Sell
8,201
-42,591
-84% -$241K 0.01% 1096
2015
Q3
$282K Sell
50,792
-35,957
-41% -$265K 0.04% 458
2015
Q2
$691K Buy
86,749
+38,094
+78% +$327K 0.1% 232
2015
Q1
$511K Buy
48,655
+34,455
+243% +$471K 0.07% 329
2014
Q4
$171K Buy
14,200
+2,500
+21% +$38K 0.03% 726
2014
Q3
$200K Buy
11,700
+3,700
+46% +$53.7K 0.03% 715
2014
Q2
$97K Sell
8,000
-48,000
-86% -$455K 0.01% 1107
2014
Q1
$473K Buy
56,000
+49,000
+700% +$395K 0.06% 425
2013
Q4
$41K Buy
+7,000
New +$36.1K 0.01% 1098

Other funds holding BDSI

Prelude Capital Management's BDSI Position: Q1 2020 in Review

Prelude Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2020, closing a stake of 13,900 shares — an estimated $88K sold.

Prelude Capital Management first reported a position in BDSI in Q4 2013 and held it in 15 quarters. The position peaked at $691K in Q2 2015. 153 funds tracked by Wall St. Rank hold BDSI as of Q1 2020.

  • Prelude Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 13,900 BioDelivery Sciences International, Inc. shares in Q1 2020, an estimated $88K.
  • Prelude Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 15 quarters.
  • Prelude Capital Management's BioDelivery Sciences International, Inc. position peaked at $691K in Q2 2015.
  • 153 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.